Finally, HML2 Env inhibition decreased the fusion of cultured melanoma cells, suggesting a role in the formation of multinuclear cancer cells and in the onset of genetic heterogeneity conferring trophic and survival advantages to tumor cells (Huang et al., 2013a). The gene discussed is ERVW-1; the disease is cancer.